StuartWongMD

Oncology • Milwaukee, WI

Associate Professor, Medicine, Medical College of Wisconsin

Join to view full profile

Dr. Wong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wong's full profile

Already have an account?

Office
9200 W Wisconsin Ave
Neoplastic Diseases
Milwaukee, WI 53226
Phone+1 414-805-6800

Fax+1 414-805-6805
Is this information wrong?

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1994 - 1998
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1990 - 1993
Medical College of WisconsinClass of 1990

Certifications & Licensure

WI State Medical License 1992 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Apr 01
Terminated
Phase 3
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Nov 01
Terminated
Phase 2
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
A Study in Advanced Solid Tumors Start of enrollment: 2010 Jun 01
Completed
Phase 2
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
Completed
Phase 2
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 2
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24
Active, not recruiting
Phase 2
Smartphone Pain App for Assessing Oral Mucositis Pain in Patients Start of enrollment: 2018 Feb 13
Active, not recruiting
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Start of enrollment: 2021 Aug 24
Active, not recruiting
Early Phase 1
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma Start of enrollment: 2018 Nov 14
Recruiting
Phase 2
Inhibition of Oral Tumorigenesis by Antitumor B Start of enrollment: 2022 Apr 22
Recruiting
Early Phase 1
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients Start of enrollment: 2021 Jul 08
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer.
Wenjing Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu, Stuart Wong, Jong-In Park> ;NPJ Precision Oncology. 2024 Feb 20
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.
Zenga, J., Awan, M., Frei, A., Foeckler, J., Kuehn, R., Espinosa, O., Bruening, J., Massey, B., Wong, S., Shreenivas, A., Shukla, M., Kasprzak, J., Sun, Y., Shaheduzza...> ;Translational Oncology. 2024 Apr 1
Good Radiosensitizer Hunting.
Loren K Mell, Stuart J Wong> ;Journal of Clinical Oncology. 2023 May 1
7 citations
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, ...> ;The Lancet. Oncology. 2023 Feb 1
1 citations
Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus.
Christina E Henson, Daniel J Morton, Jyoti S Mayadev, Stuart J Wong, Dmitriy Zamarin> ;Cancer. 2023 Mar 1
Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans.
Dinh Bui, Lenora A McWilliams, Lei Wu, Haiying Zhou, Stuart J Wong, Ming You, Diana S-L Chow, Rashim Singh, Ming Hu> ;Cancers. 2022 Dec 23
1 citations
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Cristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, Barbara Burtness, Christine H Chung, Curtis R Pickering, Carole Fakhry, Quynh Thu Le, Sue S Yom, Thomas J Gallow...> ;Journal of the National Cancer Institute. 2022 Dec 8
2 citations
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome.
Joseph Zenga, Samantha Atkinson, Tina Yen, Becky Massey, Michael Stadler, Jennifer Bruening, William Peppard, Michael Reuben, Michael Hayward, Brian Mesich, Blake Buch...> ;Ebiomedicine. 2022 Jul 1
CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Sq...
Nabil F. Saba, Stuart J. Wong, William A. Stokes, Manali Rupji, Yingzi Liu, Soumon Rudra, James E. Bates, Conor E. Steuer, J.S. Remick, K. Cummings, Nikhil P. Joshi, N...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
4 citations
Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer.
Dinh Bui, Taijun Yin, Shengnan Duan, Bo Wei, Peiying Yang, Stuart J. Wong, Ming You, Rashim Singh, Ming Hu> ;Journal of Natural Products. 2021 Sep 24
1 citations
A closer look at 30 day hospital readmissions after head and neck cancer surgery.
R. Puccia, A. Ramamurthi, S.E. Grond, C. McCormick, A. Ng, Michael E. Stadler, Becky L. Massey, Bruce H. Campbell, M.E. Shukla, Musaddiq J. Awan, Christopher J. Schult...> ;American Journal of Otolaryngology. 2021 Jun 19
5 citations
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
Julie A. Kish, Qiang Zhang, Corey J. Langer, Phuc Felix Nguyen-Tân, David I. Rosenthal, Randal S. Weber, Marcy A. List, Stuart J. Wong, Adam S. Garden, Kenneth S. Hu, ...> ;Journal of Geriatric Oncology. 2021 Apr 2
123 citations
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Benjamin Lacas, Alexandra Carmel, Cécile Landais, Stuart J. Wong, Lisa Licitra, Jeffrey S Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregor...> ;Radiotherapy and Oncology. 2021 Mar 1
1 citations
Frequent omission of radiation after flap reconstruction of head and neck cancer: Are we dooming patients to failure?
Lauren M. North, Erin Harvey, Brigitte Vanle, Aditya Shreenivas, M.E. Shukla, Stuart J. Wong, Musaddiq J. Awan, Joseph Zenga> ;Oral Oncology. 2021 Feb 18
50 citations
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies
Hisham Mehanna, Danny Rischin, Stuart J. Wong, Vincent Grégoire, Robert L. Ferris, John Waldron, Quynh-Thu Le, Martin Forster, Maura L. Gillison, Sarbani Ghosh Laskar,...> ;Journal of Clinical Oncology. 2020 Jun 4
10 citations
Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer.
Joseph Zenga, Michael E. Stadler, Becky L. Massey, Bruce H. Campbell, M.E. Shukla, Musaddiq J. Awan, Christopher J. Schultz, Stuart J. Wong, Ryan S. Jackson> ;The Laryngoscope. 2020 Mar 1
18 citations
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.
Loren K. Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, David I. Rosenthal, Kaveh Zakeri, Lucas K. Vitzthum, Steven J. Frank, Peter B. Schiff, Andy Trotti, James A. Bonner,...> ;Clinical Cancer Research. 2019 Dec 1
20 citations
Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer.
Joseph Zenga, Vasu Divi, Michael E. Stadler, Becky L. Massey, Bruce H. Campbell, M.E. Shukla, Musaddiq J. Awan, Christopher J. Schultz, Aditya Shreenivas, Stuart J. Wo...> ;Oral Oncology. 2019 Nov 1
53 citations
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensit...
Carole Fakhry, Qiang Zhang, Maura L. Gillison, Phuc Felix Nguyen-Tân, David I. Rosenthal, Randal S. Weber, Louise Lambert, Andy Trotti, William L. Barrett, Wade L. Tho...> ;Cancer. 2019 Jun 15
39 citations
Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 ...
Alexander Sun, Chen Hu, Stuart J. Wong, Elizabeth Gore, Gregory M.M. Videtic, Swati Dutta, Mohan Suntharalingam, Yuhchyau Chen, Laurie E. Gaspar, Hak Choy> ;JAMA Oncology. 2019 Jun 1
13 citations
Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
, , , , , , , , , , , , , , , , , > ;Otolaryngology--Head and Neck Surgery. 2019 Feb 12
8 citations
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination With High-Dose Interferon-α2b in Advanced Melanoma
Ahmad A. Tarhini, Sandra J. Lee, Xiaoxue Li, Uma N. M. Rao, Arun Nagarajan, Mark R. Albertini, Jerry W Mitchell, Stuart J. Wong, Mark A. Taylor, Noel Laudi, Phu Van Tr...> ;Clinical Cancer Research. 2019 Jan 15
8 citations
Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation.
Lauren M. North, Michael E. Stadler, Becky L. Massey, Bruce H. Campbell, M.E. Shukla, Musaddiq J. Awan, Christopher J. Schultz, Aditya Shreenivas, Stuart J. Wong, Evan...> ;American Journal of Otolaryngology. 2019 Jan 1
161 citations
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 express...
Dan P. Zandberg, Alain Algazi, Antonio Jimeno, J. Good, Jérôme Fayette, Nathaniel Bouganim, Neal Ready, Paul Clement, Caroline Even, Raymond Woo-Jun Jang, Stuart J. Wo...> ;European Journal of Cancer. 2019 Jan 1
1 citations
In Regard to Bossi et al.
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, David I. Rosenthal, Randal S. Weber, Maura L. Gillison, Andy Trotti, William L. Barrett, Wade L. Thorstad, Christ...> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Nov 1
Join now to see all

Journal Articles

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced Melanoma
Arun Nagarajan, Mark R Albertini, Stuart Wong, Noel Laudi, Robert M Conry, Clinical Cancer Research

Press Mentions

Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck CancerFebruary 3rd, 2023
RTOG Foundation Establishes Four New Committees; Names Committee LeadersAugust 5th, 2022
The Medical College of Wisconsin Cancer Center Awarded Top Honor, Among Top 30 Clinical Research Centers in the United StatesApril 4th, 2019